Vaccine’s Effect Evaluation

Product center>Human Diagnosis

Vaccine’s Effect Evaluation

MPn

The pathological changes of mycoplasma pneumoniae are mainly interstitial pneumonia and sometimes complicated with bronchopneumonia, which is called primary atypical pneumonia. It is mainly infected by droplet, with a incubation period of 2~3 weeks and has the highest incidence of preschool children.

Description Type Item No Source  Use for Application
MP55 rAg GHCA042 E.coli Coating/Labeling ELISA,CLIA,LFT

 

Measles Virus

Measles virus has only one serotype, and its antigenicity is stable. Measles is highly contagious. At present, the incidence of measles is more common in preschool children who have not received vaccination, teenagers and young people who have failed immunization, and even can form an epidemic in the community.

Description Type Item No Source  Use for Application
MV32 rAg GHCA036 E.coli Coating/Labeling ELISA,CLIA,LFT

JEV

The disease is mainly distributed in the Far East of Asia and southeast Asia, transmitted by mosquitoes, which will be more common in summer and autumn. It belongs to blood infectious disease.

Description Type Item No Source  Use for Application
JEV19 rAg GHCA032 E.coli Coating/Labeling ELISA,CLIA,LFT

Mumps Virus

Mumps is caused by mumps virus with parotid gland enlargement for the characteristics of acute respiratory infectious disease. Mumps viruses also cause meningitis and myocarditis and they are an important cause of acquired deafness, which is often irreversible. Inoculation of live attenuated mumps vaccine can achieve good preventive effect.

Description Type Item No Source  Use for Application
M25 rAg GHCA040 E.coli Coating/Labeling ELISA,CLIA,LFT

 

Poliovirus

Poliomyelitis is the acute infectious disease that seriously endangers children’s health that causes by poliomyelitis virus. The patient is mostly 1 ~ 6 years old children, the main symptom is fever, whole body unwell, limb ache when serious, the flaccid sex paralysis that distributes irregularly and weight differ, commonly known as poliomyelitis. After the spread of live attenuated polio vaccine, the prevention effect is good.

Description Type Item No Source  Use for Application
V17 rAg GHCA041 E.coli Coating/Labeling ELISA,CLIA,LFT

Bordetella Pertuussis

Bordetella pertussis causes pertussis in humans. Patients, especially those with mild atypical symptoms, are important sources of infection. It is mainly transmitted by droplets. The morbidity of susceptible children is close to 90%, and the mortality of children under one year old is high.

Description Type Item No Source  Use for Application
BP31 rAg GHCA008 E.coli Coating/Labeling ELISA,CLIA,LFT

Food safety

Product center>Human Diagnosis

Food safety

β-Lactams

It is recommended for specific binding of β lactam antibiotics.

Description Type Item No Source  Use for Application
P20 rAg GHCA097-1 E.coli Labeling/Coating ELISA,CLIA,LFT

CP4-EPSPS

Cp4-epsps, as a screening marker gene, and other target exogenous genes are integrated into a variety of crops, which is convenient for later screening and also endows transgenic crops with glyphosate resistance characteristics. It is convenient to use glyphosate to eliminate weeds in the field and reduce labor costs.

Description Type Item No Source  Use for Application
CP4 Antigen rAg GHCA047-1 E.coli Quality Control ELISA,CLIA,LFT
CP4-16E5 mAb GHMA093-4 mouse Labeling/Coating ELISA,CLIA,LFT
CP4-4D11 mAb GHMA093-3 mouse Labeling/Coating ELISA,CLIA,LFT

BT Cry Ab/Ac

Cry is toxic to some insects, and BT transgenic is mainly used to improve insect resistance of crops. BT protein can accumulate in the human body and its long-term toxicity cannot be underestimated. BT proteins bind to mammalian intestinal mucosal cells and, at high concentrations, may be toxic to mammals. BT protein can inhibit the immune function and hematopoietic function of the body and cause autoimmune diseases and other potential dangers.

Description Type Item No Source  Use for Application
Cry-2B7 mAb GHMA094-1 mouse Labeling ELISA,CLIA,LFT
Cry-6E9 mAb GHMA094-2 mouse Coating ELISA,CLIA,LFT